Beauclair, G., Naimo, E., Dubich, T., Rückert, J., Koch, S., Dhingra, A., . . . Schulz, T. F. (2020). Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use. J Virol.

Beauclair, Guillaume, Eleonora Naimo, Tatyana Dubich, Jessica Rückert, Sandra Koch, Akshay Dhingra, Dagmar Wirth, und Thomas F. Schulz. "Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation By Tyrosine Kinase Inhibitors Approved for Clinical Use." J Virol 2020.

Beauclair, Guillaume, et al. "Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation By Tyrosine Kinase Inhibitors Approved for Clinical Use." J Virol 2020.